Serum sphingolipid profiling as a novel biomarker for metabolic syndrome characterization

BACKGROUND: Sphingolipids are components of cell membrane structure, but also circulate in serum and are essential mediators of many cellular functions. While ceramides have been proposed previously as a useful biomarker for cardiometabolic disease, the involvement of other sphingolipids is still co...

Descripción completa

Detalles Bibliográficos
Autores principales: Berkowitz, Loni, Salazar, Cristian, Ryff, Carol D., Coe, Christopher L., Rigotti, Attilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791223/
https://www.ncbi.nlm.nih.gov/pubmed/36578837
http://dx.doi.org/10.3389/fcvm.2022.1092331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791223/
https://www.ncbi.nlm.nih.gov/pubmed/36578837
http://dx.doi.org/10.3389/fcvm.2022.1092331

Ejemplares similares